Bacterial pneumonia: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

See pneumonia for a general overview of pneumonia and its other causes.
Bacterial pneumonia
Classification and external resources
ICD-10 J13.-J16.
ICD-9 481-483
eMedicine emerg/465 med/1852
MeSH D018410

Bacterial pneumonia is a type of pneumonia associated with bacterial infection.[1]


Sign and symptoms



Gram positive

Streptococcus pneumoniae (J13.) is the most common bacterial cause of pneumonia in all age groups except newborn infants. Streptococcus pneumoniae is a Gram-positive bacteria which often lives in the throat of people who do not have pneumonia.

Another important Gram-positive cause of pneumonia is Staphylococcus aureus (J15.2).

Gram negative

Gram-negative bacteria are seen less frequently: Haemophilus influenzae (J14.), Klebsiella pneumoniae (J15.0), Escherichia coli (J15.5), Pseudomonas aeruginosa (J15.1) and Moraxella catarrhalis are the most common.

These bacteria often live in the gut and enter the lungs when contents of the gut (such as vomit or faeces) are inhaled.

Streptococcus pneumoniae-263.jpg
Infectious pneumonias
Pneumonias caused by infectious or noninfectious agents
Noninfectious pneumonia


"atypical" bacteria are Coxiella burnetti, Chlamydophila pneumoniae (J16.0), Mycoplasma pneumoniae (J15.7), and Legionella pneumophila.

They are "atypical" because they are not the common pneumonia-causing bacteria, are not responding on common antibiotics and cause atypical symptoms.

Course of the disease

Bacteria typically enters the lung with inhalation, though they can reach the lung through the bloodstream if other parts of the body are infected. Often, bacteria live in parts of the upper respiratory tract and are continually being inhaled into the alveoli. Once inside the alveoli, bacteria travel into the spaces between the cells and also between adjacent alveoli through connecting pores. This invasion triggers the immune system to respond by sending white blood cells responsible for attacking microorganisms (neutrophils) to the lungs. The neutrophils engulf and kill the offending organisms but also release cytokines which result in a general activation of the immune system. This results in the fever, chills, and fatigue common in bacterial and fungal pneumonia. The neutrophils, bacteria, and fluid leaked from surrounding blood vessels fill the alveoli and result in impaired oxygen transportation.

Bacteria often travel from the lung into the blood stream and can result in serious illness such as septic shock, in which there is low blood pressure leading to damage in multiple parts of the body including the brain, kidney, and heart. They can also travel to the area between the lungs and the chest wall, called the pleural cavity.


Antibiotics are the treatment of choice for bacterial pneumonia. The antibiotic choice depends on the nature of the pneumonia, the microorganisms most commonly causing pneumonia in the geographical region, and the immune status and underlying health of the individual. In the United Kingdom, amoxicillin is used as first-line therapy in the vast majority of patients who acquire pneumonia in the community, sometimes with added clarithromycin. In North America, where the "atypical" forms of community-acquired pneumonia are becoming more common, clarithromycin, azithromycin, or fluoroquinolones as single therapy, have displaced the amoxicillin as first-line therapy. Local patterns of antibiotic-resistance should always be considered when initiating pharmacotherapy. In hospitalized individuals or those with immune deficiencies, local guidelines determine the selection of antibiotics. These antibiotics are typically given through an intravenous line.

Treatment of gram-positive organisms

Streptococcus pneumoniae - amoxicillin (or erythromycin in patients allergic to penicillin); cefuroxime and erythromycin in severe cases. Staphylococcus aureus - flucloxacillin (to counteract the organism's β-lactamase)

Treatment of gram-negative organisms

  • Haemophilus influenzae - doxycycline
  • Klebsiella pneumoniae
  • Escherichia coli
  • Pseudomonas aeruginosa ciprofloxicin
  • Moraxella catarrhalis

Treatment of atypical organisms

Most atypical causes of pneumonia require treatment for 14-21 days.

  • Chlamydophila pneumoniae - doxycycline
  • Chlamydophila psittaci - erythromycin
  • Mycoplasma pneumoniae - erythromycin
  • Coxiella burnetti - erythromycin
  • Legionella pneumophila - erythromycin, with rifampicin sometimes added.

People who have difficulty breathing due to pneumonia may require extra oxygen. An extremely sick individual may require artificial ventilation and intensive care as life-saving measures while his or her immune system fights off the infectious cause with the help of antibiotics and other drugs.


External links


Got something to say? Make a comment.
Your name
Your email address